NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 8 filers reported holding NOVELION THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $26,000 | -7.1% | 36,428 | 0.0% | 0.01% | +60.0% |
| Q2 2019 | $28,000 | -37.8% | 36,428 | 0.0% | 0.01% | -61.5% |
| Q1 2019 | $45,000 | +45.2% | 36,428 | 0.0% | 0.01% | +30.0% |
| Q4 2018 | $31,000 | -71.3% | 36,428 | 0.0% | 0.01% | -50.0% |
| Q3 2018 | $108,000 | -19.4% | 36,428 | 0.0% | 0.02% | -39.4% |
| Q2 2018 | $134,000 | +5.5% | 36,428 | 0.0% | 0.03% | +13.8% |
| Q1 2018 | $127,000 | +11.4% | 36,428 | 0.0% | 0.03% | -21.6% |
| Q4 2017 | $114,000 | -55.5% | 36,428 | 0.0% | 0.04% | -56.5% |
| Q3 2017 | $256,000 | -23.8% | 36,428 | 0.0% | 0.08% | -15.0% |
| Q2 2017 | $336,000 | -14.1% | 36,428 | 0.0% | 0.10% | -28.6% |
| Q1 2017 | $391,000 | – | 36,428 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,524,034 | $12,832,000 | 7.64% |
| Healthcare Value Capital, LLC | 831,440 | $7,001,000 | 7.50% |
| ARMISTICE CAPITAL, LLC | 1,420,000 | $11,956,000 | 2.83% |
| Sarissa Capital Management LP | 1,025,000 | $8,630,000 | 2.38% |
| Broadfin Capital, LLC | 1,948,554 | $16,407,000 | 1.82% |
| JW Asset Management, LLC | 324,280 | $2,731,000 | 1.82% |
| Tiger Legatus Capital Management, LLC | 320,000 | $2,694,000 | 1.00% |
| Kingstown Capital | 599,998 | $5,052,000 | 0.50% |
| KNOTT DAVID M | 109,184 | $919,000 | 0.46% |
| Ancora Advisors LLC | 560,613 | $4,721,000 | 0.34% |